Magnetic Nanoparticles with On-Site Azide and Alkyne Functionalized Polymer Coating in a Single Step through a Solvothermal Process
<b>Background/Objectives</b>: Magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles (MNPs) are becoming more important every day. We prepared MNPs in a simple one-step reaction by following the solvothermal method, assisted by azide and alkyne functionalized polyethylene glycol (PEG400) polymers, as well as by PEG6000 and the polyol β-cyclodextrin (βCD), which played a crucial role as electrostatic stabilizers, providing polymeric/polyol coatings around the magnetic cores. <b>Methods</b>: The composition, morphology, and magnetic properties of the nanospheres were analyzed using Transmission Electron and Atomic Force Microscopies (TEM, AFM), Nuclear Magnetic Resonance (NMR), X-ray Diffraction Diffractometry (XRD), Fourier-Transform Infrared Spectroscopy (FT-IR), Matrix-Assisted Laser Desorption/Ionization (MALDI) and Vibrating Sample Magnetometry (VSM). <b>Results</b>: The obtained nanoparticles (@Fe<sub>3</sub>O<sub>4</sub>-PEGs and @Fe<sub>3</sub>O<sub>4</sub>-βCD) showed diameters between 90 and 250 nm, depending on the polymer used and the Fe<sub>3</sub>O<sub>4</sub>·6H<sub>2</sub>O precursor concentration, typically, 0.13 M at 200 °C and 24 h of reaction. MNPs exhibited superparamagnetism with high saturation mass magnetization at room temperature, reaching values of 59.9 emu/g (@Fe<sub>3</sub>O<sub>4</sub>-PEG6000), and no ferromagnetism. Likewise, they showed temperature elevation after applying an alternating magnetic field (AMF), obtaining Specific Absorption Rate (SAR) values of up to 51.87 ± 2.23 W/g for @Fe<sub>3</sub>O<sub>4</sub>-PEG6000. Additionally, the formed systems are susceptible to click chemistry, as was demonstrated in the case of the cannabidiol-propargyl derivative (CBD-Pro), which was synthesized and covalently attached to the azide functionalized surface of @Fe<sub>3</sub>O<sub>4</sub>-PEG400-N<sub>3</sub>. Prepared MNPs are highly dispersible in water, PBS, and citrate buffer, remaining in suspension for over 2 weeks, and non-toxic in the T84 human colon cancer cell line, <b>Conclusions</b>: indicating that they are ideal candidates for biomedical applications.
Authors
- Lidia Gago (ORCID: https://orcid.org/0000-0003-1806-0987)
- Laura Cabeza (ORCID: https://orcid.org/0000-0001-9369-5945)
- Consolación Melguizo (ORCID: https://orcid.org/0000-0003-3990-806X)
- David Fuentes‐Ríos (ORCID: https://orcid.org/0000-0002-6888-0847)
- Francisco Sarabia (ORCID: https://orcid.org/0000-0002-5149-3576)
- Juan Manuel López‐Romero (ORCID: https://orcid.org/0000-0003-2422-655X)
- Ana Moscoso
- José Prados (ORCID: https://orcid.org/0000-0003-4303-7746)
- ROMUALDO MORA-CABELLO
Institutions
- Universidad de Granada (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2024-09-19
- DOI
- https://doi.org/10.3390/pharmaceutics16091226
- Citations
- 4
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.69